Evidence map›Paper›PMID 17297932›Full record

ArticleAnalytical chemistry2007

Microscale enzymatic optical biosensors using mass transport limiting nanofilms. 1. Fabrication and characterization using glucose as a model analyte.

Erich W Stein, Patrick S Grant, Huiguang Zhu, Michael J McShane

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Enzymatic Glucose Sensor Compensation for Variations in Ambient Oxygen Concentration.Proceedings of SPIE--the International Society for Optical Engineering · 2015
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Erich W SteinBiomedical Engineering Program and The Institute for Micromanufacturing, Louisiana Tech University, Ruston, Louisiana 71272, USA.
Patrick S Grant
Huiguang Zhu
Michael J McShane
Texas A&M University · US

Funding

Fluorescent Glucose Sensors from Polyion MicroshellsR01EB000739 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI MCSHANE, MIKE · 2002 to 2006
$1.3M
NIBIB NIH HHS R01 EB000739
6 · The paper itself

Abstract

"Smart tattoo" sensors-fluorescent microspheres that can be implanted intradermally and interrogated noninvasively using light-are being developed as potential tools for in vivo biochemical monitoring. In this work, a platform for enzymatic tattoo-type sensors is described and prototype devices evaluated using glucose as a model analyte. Sensor particles were prepared by immobilizing Pt(II) octaethylporphine (PtOEP), a phosphorescent dye readily quenched by molecular oxygen, into hybrid silicate microspheres, followed by loading and subsequent covalent immobilization of glucose oxidase. Rhodamine B-doped multilayer nanofilms were subsequently assembled on the surfaces of the particles to provide a reference signal and provide critical control of glucose transport into the particle. The enzymatic oxidation of glucose within the sensor results in the glucose concentration-dependent depletion of local oxygen levels, enabling indirect monitoring of glucose by measuring relative changes in PtOEP emission. A custom testing apparatus was used to monitor the dynamic sensor response to varying bulk oxygen and glucose levels, respectively. For the prototypes tested, dynamic test results indicate that the sensors respond rapidly (t(95) = 84 s) and reversibly to changes in bulk glucose levels, while demonstrating high baseline stability. The sensitivity (change in intensity ratio) of these devices was determined to be 4.16 +/- 0.57%/mg dL(-1). The analytical range for the prototypes was determined to be 2-120 mg/dl, though this can be extended to cover the physiologically relevant range by tailoring the nanofilm coatings. These findings confirm the potential for enzymatic microscale optical and pave the way for extension of this initial demonstration with glucose to target other biochemical species relevant to metabolic monitoring.

Indexed as

Optics and PhotonicsAdsorptionBiosensing TechniquesEnzymes, ImmobilizedGlucoseGlucose OxidaseHydrogen-Ion ConcentrationMembranes, ArtificialNanostructuresOrganoplatinum CompoundsOxidation-ReductionOxygenParticle SizeRhodaminesSilicon DioxideStructure-Activity RelationshipEnzymes, ImmobilizedGlucoseGlucose OxidaseMembranes, ArtificialOrganoplatinum CompoundsOxygenrhodamine BRhodaminesSilicon Dioxide

Identifiers

PMID17297932
PMCPMC2518633
OpenAlexW1965093113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.